Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Yuanli Chemical Group Co.,Ltd. (603217.SS)
Weifang, CN
Yuanli Chemical Group Co.,Ltd. specializes in the innovation, manufacturing, and global distribution of fine chemicals. Its product portfolio includes environmentally friendly solvents, dual-alcohol compounds, tailored plasticizers, and effective coalescing agents. These offerings cater to a diverse range of sectors, such as coatings, polymers, plastic additives, pigments, pharmaceuticals, and broader chemical applications. The company boasts an international reach, distributing its products to approximately 50 countries and regions worldwide. Founded in 2003 and headquartered in Weifang, China, the enterprise was formerly identified as Shandong Yuanli Science and Technology Co.,Ltd.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -6.49% | -7.33% | -12.73% | -5.40% | -6.62% | +4.61% | +57.55% | +3.80% | +43.16% | -24.14% | -24.14% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%-1.9% Q1'26: +9.6% (vs Q1'25)
-
EPS growth Chemicals: +11.7%-7.9% Q1'26: +31.8% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%-5.5% Q1'26: -18.4% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%+10.3% ★ Q1'26: +11.3% (vs Q1'25)
-
ROIC Chemicals: +3.4%+7.5% ★ Q1'26: +9.3% (vs Q1'25)
-
Share dilution Chemicals: +0.0%+1.3% Q1'26: -1.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×2.73× ★ Q1'26: 2.38× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|
| Revenue |
2.34B
est: 2.30B (+1.8%)
|
2.68B
est: 2.84B (-5.4%)
|
2.18B
est: 2.29B (-4.7%)
|
2.22B
est: 2.49B (-11.0%)
|
2.18B
est: 2.30B (-5.4%)
|
2.87B
2.87B – 2.87B
+24.6% YoY
|
3.41B
3.41B – 3.41B
+18.9% YoY
|
3.63B
3.63B – 3.63B
+6.4% YoY
|
| EBITDA |
509.63M
est: 460.31M (+10.7%)
|
618.47M
est: 567.09M (+9.1%)
|
398.31M
est: 457.51M (-12.9%)
|
340.89M
est: 469.28M (-27.4%)
|
341.68M
est: 433.19M (-21.1%)
|
539.63M
539.63M – 539.63M
+24.6% YoY
|
641.65M
641.65M – 641.65M
+18.9% YoY
|
682.68M
682.68M – 682.68M
+6.4% YoY
|
| EBIT |
421.39M
est: 357.62M (+17.8%)
|
536.60M
est: 440.58M (+21.8%)
|
302.57M
est: 355.45M (-14.9%)
|
242.74M
est: 364.19M (-33.3%)
|
223.07M
est: 336.18M (-33.6%)
|
418.79M
418.79M – 418.79M
+24.6% YoY
|
497.96M
497.96M – 497.96M
+18.9% YoY
|
529.80M
529.80M – 529.80M
+6.4% YoY
|
| Net Income |
360.11M
est: 358.89M (+0.3%)
|
469.33M
est: 471.68M (-0.5%)
|
249.68M
est: 244.04M (+2.3%)
|
207.13M
est: 272.03M (-23.9%)
|
193.12M
est: 219.08M (-11.8%)
|
245.04M
245.04M – 245.04M
+11.8% YoY
|
294.87M
294.87M – 294.87M
+20.3% YoY
|
355.09M
355.09M – 355.09M
+20.4% YoY
|
| SGA |
58.40M
est: 34.84M (+67.6%)
|
98.15M
est: 42.92M (+128.7%)
|
82.96M
est: 34.63M (+139.6%)
|
81.18M
est: 74.78M (+8.6%)
|
30.17M
est: 69.03M (-56.3%)
|
85.99M
85.99M – 85.99M
+24.6% YoY
|
102.25M
102.25M – 102.25M
+18.9% YoY
|
108.79M
108.79M – 108.79M
+6.4% YoY
|
| EPS |
1.77
est: 1.75 (+1.1%)
|
2.86
est: 2.30 (+24.3%)
|
1.21
est: 1.19 (+1.7%)
|
1.01
est: 1.31 (-22.9%)
|
0.93
est: 1.06 (-11.8%)
|
1.18
1.18 – 1.18
+11.8% YoY
|
1.42
1.42 – 1.42
+20.3% YoY
|
1.71
1.71 – 1.71
+20.4% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-28 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-27 | B+ | 3/5 | 3/5 | 4/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-26 | B+ | 3/5 | 3/5 | 4/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-25 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-22 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-21 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-20 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-19 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-18 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-15 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-14 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-13 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-12 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-11 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-08 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-07 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-06 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-30 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-29 | B | 3/5 | 3/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-28 | B | 3/5 | 3/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-27 | B | 3/5 | 3/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-24 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-23 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-22 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-21 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-20 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-17 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-16 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Guoliang Feng | Director, Deputy GM & Board Secretary | — | male |
| Jiawei Liu | Deputy GM & Director | — | male |
| Ping Wang | Deputy General Manager | — | female |
| Wang Junyu | Deputy GM & Director | — | male |
| Yitian Li | General Manager | — | male |
| Yujiang Liu | Director, Deputy GM, Account Supervisor & Chief Financial Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 603217.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
